Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden · Delayed Price · Currency is SEK 169.40
-7.60 (-4.29%)
Sep 2, 2025, 5:29 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 5.34 billion as of September 2, 2025. Its market cap has decreased by -67.73% in one year.
Market Cap
5.34B
Enterprise Value
5.12B
Revenue
822.93M
Ranking
n/a
PE Ratio
48.44
Stock Price
169.40
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 5.34B, an increase of 1,335.60%. That is a compound annual growth rate of 22.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 5.34B | -65.36% |
| Dec 30, 2024 | 15.40B | 48.41% |
| Dec 29, 2023 | 10.38B | 90.12% |
| Dec 30, 2022 | 5.46B | -33.55% |
| Dec 30, 2021 | 8.22B | -8.90% |
| Dec 30, 2020 | 9.02B | 99.42% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 95.17B |
| Sectra AB | 64.36B |
| Getinge AB | 57.09B |
| Camurus AB | 43.14B |
| Medicover AB | 39.63B |
| Asker Healthcare Group AB | 35.63B |
| BioArctic AB | 28.06B |
| AddLife AB | 21.33B |